Funding awarded
- Deciphering the fitness determinants of clonal mosaicism- ELA Stage II awarded by The Mark Foundation for Cancer Research Key Personnel 2025 - 2026
- Charting the differentiation topology of SF3B1 mutated clonal hematopoiesis (CH) and myelodysplastic syndromes (MDS) via a multi-omics single-cell toolkit awarded by National Heart, Lung, & Blood Institute Key Personnel 2022 - 2026